Compare Oruka Therapeutics Inc. Common Stock (ORKA) vs Workday Inc (WDAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oruka Therapeutics Inc. Common Stock vs Workday Inc — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B), while Workday Inc trades at $192 (market cap $44.83B). The key difference: Workday Inc is far larger — about 8.7× Oruka Therapeutics Inc. Common Stock's market cap, and Oruka Therapeutics Inc. Common Stock is more actively traded (490,798 versus 2,168,736). Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and Workday Inc for 38 Days on average.
| ORKA | WDAY | |
|---|---|---|
Market Cap | $5.18B | $44.83B |
Volume | 490,798 | 2,168,736 |
Sector | Health | Technology |
52-Week High | $113.08 | $245.67 |
52-Week Low | $26.19 | $112.55 |
Typical Hold Time | 0 Days | 38 Days |
Enterprise Value | $4.31B | $45.20B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Workday (WDAY) trades at $188.77, up 0.28% today, with a bullish technical signal from moving averages and a consensus analyst price target of $203.19. The company has beaten earnings estimates for the last three quarters, with Q3 2026 EPS expected at $2.74. Revenue grew to $8.45 billion in 2025, and recent news highlights AI product launches and strategic partnerships, though layoffs and a fraud investigation present headwinds.
WDAY offers growth potential driven by AI integration and expanding market presence, but faces risks from competitive pressures and execution challenges. The stock's valuation multiples are elevated, requiring sustained earnings growth to justify current levels. Investor sentiment is mixed amid operational adjustments and legal scrutiny.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →About Workday Inc
Workday is a software company that offers human capital management, or HCM, financial management, and business planning solutions. Known for being a cloud-only software provider, Workday is headquartered in Pleasanton, California. Founded in 2005, Workday now employs over 12,000 employees.
Read more on WDAY →
